BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 702335)

  • 1. The effect of delta9-tetrahydrocannabinol on the conversion of [3H]trypotphan to 5-[3H] hydroxytryptamine in the mouse brain.
    Johnson KM; Dewey WL
    J Pharmacol Exp Ther; 1978 Oct; 207(1):140-50. PubMed ID: 702335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of delta9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes.
    Bloom AS
    J Pharmacol Exp Ther; 1982 Apr; 221(1):97-103. PubMed ID: 6278139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the pharmacokinetics of 3H-delta9-tetrahydrocannabinol in mice by bacterial endotoxin.
    Martin BR; Montgomery J; Dewey WL; Harris LS
    Drug Metab Dispos; 1978; 6(3):282-7. PubMed ID: 26549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of delta9-THC on the synaptosomal uptake of 3H-tryptophan and 3H-choline.
    Johnson KM; Dewey WL
    Pharmacology; 1978; 17(2):83-7. PubMed ID: 684080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coincidence of blockade of synaptosomal 5-hydroxytryptamine uptake and decrease in tryptophan hydroxylase activity: effects of fenfluramine.
    Knapp S; Mandell AJ
    J Pharmacol Exp Ther; 1976 Jul; 198(1):123-32. PubMed ID: 933002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lithium chloride on parameters biosynthetic capacity for 5-hydroxytryptamin in rat brain.
    Knapp S; Mandell AJ
    J Pharmacol Exp Ther; 1975 Jun; 193(3):812-23. PubMed ID: 1151731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
    Williams IJ; Edwards S; Rubo A; Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2006 Jun; 539(1-2):57-63. PubMed ID: 16687136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes.
    Banerjee SP; Snyder SH; Mechoulam R
    J Pharmacol Exp Ther; 1975 Jul; 194(1):74-81. PubMed ID: 168349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of repeated administration of delta9-tetrahydrocannabinol on serotonin metabolism in the rat brain.
    Sofia RD; Dixit BN; Barry H
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):52-8. PubMed ID: 931467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol sedation is reduced by delta9-tetrahydrocannabinol in mice.
    Brand PA; Paris A; Bein B; Meybohm P; Scholz J; Ohnesorge H; Tonner PH
    Anesth Analg; 2008 Jul; 107(1):102-6. PubMed ID: 18635473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study.
    Watanabe A; Hasegawa S; Nishi K; Nguyen KQ; Diksic M
    Brain Res Bull; 2006 Mar; 69(2):101-8. PubMed ID: 16533657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenalectomy reverses the effects of delta-9-THC on mouse brain 5-hydroxytryptamine turnover.
    Johnson KM; Dewey WL; Bloom AS
    Pharmacology; 1981; 23(4):223-9. PubMed ID: 6275421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro alteration of the subcellular distribution of 3H-reserpine in the rat forebrain by delta 9-tetrahydrocannabinol.
    Johnson KM; Dewey WL; Ho BT
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):655-71. PubMed ID: 1005913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
    Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
    Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acute and chronic tramadol on [3H]-5-HT uptake in rat cortical synaptosomes.
    Giusti P; Buriani A; Cima L; Lipartiti M
    Br J Pharmacol; 1997 Sep; 122(2):302-6. PubMed ID: 9313939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neurobiological model for the symmetrical prophylactic action of lithium in bipolar affective disorder.
    Mandell AJ; Knapp S
    Pharmakopsychiatr Neuropsychopharmakol; 1976 May; 9(3):116-26. PubMed ID: 988597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the selectivity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol: complete substitution with methanandamide.
    Alici T; Appel JB
    Pharmacol Biochem Behav; 2004 Nov; 79(3):431-7. PubMed ID: 15582014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship of substitutions at the C-1 position of Delta9-tetrahydrocannabinol.
    Burdick D; DeOrazio R; Guzzo P; Habershaw A; Helle M; Paul B; Wolf M
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1424-6. PubMed ID: 20079638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.